The SYK Inhibitor Fostamatinib Limits Tissue Damage and Fibrosis in a Bleomycin-Induced Scleroderma MOUSE MODEL

被引:0
|
作者
Pamuk, Omer Nuri [1 ]
Can, Guray [1 ]
Ayvaz, Suleyman [1 ]
Karaca, Turan [1 ]
Pamuk, Gulsum [1 ]
Demirtas, Selim [1 ]
Tsokos, George C. [2 ]
机构
[1] Trakya Univ, Fac Med, Edirne, Turkey
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1725
引用
收藏
页码:S759 / S759
页数:1
相关论文
共 50 条
  • [1] Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model
    Pamuk, O. N.
    Can, G.
    Ayvaz, S.
    Karaca, T.
    Pamuk, G. E.
    Demirtas, S.
    Tsokos, G. C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : S15 - S22
  • [2] Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma
    Aung, Wah Wah
    Wang, Chenyang
    Xibei, Jia
    Horii, Motoki
    Mizumaki, Kie
    Kano, Miyu
    Okamura, Ai
    Kobayashi, Tadahiro
    Matsushita, Takashi
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2021, 101 (03) : 174 - 184
  • [3] CD109 Overexpression Ameliorates Skin Fibrosis in a Mouse Model of Bleomycin-Induced Scleroderma
    Vorstenbosch, Joshua
    Al-Ajmi, Hasan
    Winocour, Sebastian
    Trzeciak, Alissa
    Lessard, Lucie
    Philip, Anie
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (05): : 1378 - 1383
  • [4] OCTREOTIDE AMELIORATES DERMAL FIBROSIS IN BLEOMYCIN-INDUCED SCLERODERMA
    Orhan, S. O.
    Yolbas, S.
    Yildirim, A.
    Tektemur, A.
    Ozercan, I. H.
    Onalan, E.
    Koca, S. S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 962 - 963
  • [5] LAPATINIB AMELIORATES DERMAL FIBROSIS IN BLEOMYCIN-INDUCED SCLERODERMA
    Karatepe, B. A.
    Yolbas, S.
    Yildirim, A.
    Celik, Z. B.
    Ozercan, I. H.
    Onalan, E.
    Koca, S. S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 962 - 962
  • [6] Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma
    Oyucu Orhan, Sibel
    Tektemur, Ahmet
    Gozel, Nevzat
    Ozercan, Ibrahim Hanifi
    Yolbas, Servet
    Yildirim, Ahmet
    Onalan, Ebru
    Koca, Suleyman Serdar
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 886 - 891
  • [7] The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis Cilengitide and Bleomycin-Induced Pulmonary Fibrosis
    Ritzenthaler, Jeffrey D.
    Zhang, Michael
    Torres-Gonzalez, Edilson
    Roman, Jesse
    [J]. LUNG, 2020, 198 (06) : 947 - 955
  • [8] Aucubin Alleviates Bleomycin-Induced Pulmonary Fibrosis in a Mouse Model
    Zhou, Yong
    Li, Ping
    Duan, Jia-Xi
    Liu, Tian
    Guan, Xin-Xin
    Mei, Wen-Xiu
    Liu, Yong-Ping
    Sun, Guo-Ying
    Wan, Li
    Zhong, Wen-Jing
    Ouyang, Dong-Sheng
    Guan, Cha-Xiang
    [J]. INFLAMMATION, 2017, 40 (06) : 2062 - 2073
  • [9] Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma
    Diddi, Snehalatha
    Bale, Swarna
    Pulivendala, Gauthami
    Godugu, Chandraiah
    [J]. INFLAMMOPHARMACOLOGY, 2019, 27 (01) : 139 - 149
  • [10] Aucubin Alleviates Bleomycin-Induced Pulmonary Fibrosis in a Mouse Model
    Yong Zhou
    Ping Li
    Jia-Xi Duan
    Tian Liu
    Xin-Xin Guan
    Wen-Xiu Mei
    Yong-Ping Liu
    Guo-Ying Sun
    Li Wan
    Wen-Jing Zhong
    Dong-Sheng Ouyang
    Cha-Xiang Guan
    [J]. Inflammation, 2017, 40 : 2062 - 2073